Search Results 391-400 of 15804 for anti-TNF drugs
By blocking these chemicals, targeted therapy treatments cause cancer cells to die. Targeted therapy medicines can be injected into the cancer to treat ...
The April issue of Mayo Clinic Health Letter covers the risks of nonsteroidal anti-inflammatory drugs (NSAIDs) that include celecoxib (Celebrex), diclofenac ( ...
Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...
- Treated with any anti-cancer therapy within 30 days prior to the first virus injection. Anti-cancer therapy is defined as anti-cancer agents (e.g. surgery,
... medications for Crohn's disease therapy -Prior treatment failure or intolerance with at least one Anti Tumor Necrosis Factor-Alpha Therapy (anti-TNF α) agent.
Mayo Clinic is developing ways to use nanoparticles to modify adipose-derived mesenchymal stem cells to secrete anti-tumor proteins. The therapy can then be ...
Rituximab, an anti-CD20 chimeric antibody, was approved by the United States Food and Drug Administration in 1998 for the treatment of patients with relapsed ...
Chemotherapy drugs, such as carboplatin and ... Patients with a creatinine clearance between 45 and 79 mL/min should not use ibuprofen or other nonsteroidal anti ...
Intravitreous anti-vascular endothelial growth factor (anti-VEGF) therapy alone or vitrectomy combined with intraoperative PRP each provide the opportunity to ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.